Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2007; 13(31): 4264-4267
Published online Aug 21, 2007. doi: 10.3748/wjg.v13.i31.4264
Published online Aug 21, 2007. doi: 10.3748/wjg.v13.i31.4264
Table 1 Baseline characteristics of patients
Group A | Group B | Group C | |
Characteristics | (LVD, 100 mg/d) | (ETV, 0.5 mg/d) | (ETV, 1.0 mg/d) |
Patients (n) | 21 | 21 | 19 |
Age ( yr) | 31 ± 12 | 33 ± 10 | 31 ± 11 |
Sex ( M/F ) | 11/10 | 12/9 | 11/8 |
HBV DNA (log copies/mL) | 8.49 ± 1.10 | 8.52 ± 1.02 | 8.60 ± 0.90 |
ALT (IU/L) | 201.6 ± 178.2 | 211.2 ± 144.7 | 198.9 ± 169.5 |
- Citation: Ren FY, Piao DM, Piao XX. A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B. World J Gastroenterol 2007; 13(31): 4264-4267
- URL: https://www.wjgnet.com/1007-9327/full/v13/i31/4264.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i31.4264